Testing a dual-action drug for diabetes and early memory loss
Treatments studied
Part of Blood & lymphatic, Brain & nervous system, Cancer, Hormones & metabolism, Immune system & allergy, Mental health clinical trials.
This study tests if a new type of diabetes drug that targets two natural hormones can help people with type 2 diabetes who also have early memory problems. If you have type 2 diabetes and mild cognitive impairment or mild dementia, this trial may offer a potential treatment option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 2 diabetes.
- You are between 50 and 75 years old.
- You have mild memory or thinking problems that started at least 6 months ago.
- Your blood sugar has been stable for the last 3 months, either with diet alone, pills, or once-daily insulin.
- You are not currently taking certain diabetes drugs like Ozempic or Mounjaro.
- You are willing to have MRI scans of your brain.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at ways to catch early thinking and memory changes in people with type 2 diabetes. By joining, you may help doctors learn how to spot problems sooner and find better ways to help.
This study tests if a combination of insulin and semaglutide (a diabetes drug) can improve memory and thinking in people with mild cognitive impairment (MCI) who also have metabolic syndrome (a cluster of health issues like large waist, high blood sugar, and high blood pressure). It aims to see if treating blood sugar problems helps protect the brain.
This trial tests if combining exercise with a diabetes medication (semaglutide) can improve memory and thinking in older adults with type 2 diabetes. You may benefit if you are 65 or older, have high blood sugar, and are not already exercising regularly.
This study screens older adults with type 2 diabetes for early signs of memory or thinking problems, and offers a program to help keep the brain healthy. It aims to find out if a combination of lifestyle changes, mental exercises, and medical support can slow cognitive decline.
This trial tests an investigational drug called HDM1005 for people with type 2 diabetes whose blood sugar is still high despite taking metformin (with or without another diabetes pill called an SGLT2 inhibitor). The goal is to see if the new drug can better lower blood sugar levels.
This study tests a new medication, CORT108297, that may help protect the brain from the harmful effects of stress in people at risk for Alzheimer's disease. It is looking for adults age 55 and older who either have mild memory problems or are healthy but have a family history, APOE4 gene, or memory concerns.
Hear when a new Dementia, Mild trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.